» Articles » PMID: 23371301

A New Model for Preclinical Testing of Dermal Substitutes for Human Skin Reconstruction

Overview
Date 2013 Feb 2
PMID 23371301
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Currently, acellular dermal substitutes used for skin reconstruction are usually covered with split-thickness skin grafts. The goal of this study was to develop an animal model in which such dermal substitutes can be tested under standardized conditions using a bioengineered dermo-epidermal skin graft for coverage.

Methods: Bioengineered grafts consisting of collagen type I hydrogels with incorporated human fibroblasts and human keratinocytes seeded on these gels were produced. Two different dermal substitutes, namely Matriderm(®), and an acellular collagen type I hydrogel, were applied onto full-thickness skin wounds created on the back of immuno-incompetent rats. As control, no dermal substitute was used. As coverage for the dermal substitutes either the bioengineered grafts were used, or, as controls, human split-thickness skin or neonatal rat epidermis were used. Grafts were excised 21 days post-transplantation. Histology and immunofluorescence was performed to investigate survival, epidermis formation, and vascularization of the grafts.

Results: The bioengineered grafts survived on all tested dermal substitutes. Epidermis formation and vascularization were comparable to the controls.

Conclusion: We could successfully use human bioengineered grafts to test different dermal substitutes. This novel model can be used to investigate newly designed dermal substitutes in detail and in a standardized way.

Citing Articles

Acellular dermal matrix in skin wound healing in rabbits - histological and histomorphometric analyses.

Carvalho-Junior J, Zanata F, Aloise A, Ferreira L Clinics (Sao Paulo). 2021; 76:e2066.

PMID: 33681941 PMC: 7920408. DOI: 10.6061/clinics/2021/e2066.


Development of humanized mouse and rat models with full-thickness human skin and autologous immune cells.

Agarwal Y, Beatty C, Ho S, Thurlow L, Das A, Kelly S Sci Rep. 2020; 10(1):14598.

PMID: 32884084 PMC: 7471691. DOI: 10.1038/s41598-020-71548-z.


Down-Regulation of MHC Class I Expression in Human Keratinocytes Using Viral Vectors Containing Gene of Human Cytomegalovirus and Cultivation on Bovine Collagen-Elastin Matrix (Matriderm): Potential Approach for an Immune-Privileged Skin Substitute.

Schlottmann F, Strauss S, Hake K, Vogt P, Bucan V Int J Mol Sci. 2019; 20(9).

PMID: 31027326 PMC: 6540026. DOI: 10.3390/ijms20092056.


Impact of human mesenchymal cells of different body site origins on the maturation of dermo-epidermal skin substitutes.

Michalak-Micka K, Klar A, Bottcher-Haberzeth S, Reichmann E, Meuli M, Biedermann T Pediatr Surg Int. 2018; 35(1):121-127.

PMID: 30382375 DOI: 10.1007/s00383-018-4383-5.


Engineering epithelial-stromal interactions in vitro for toxicology assessment.

Belair D, Abbott B Toxicology. 2017; 382:93-107.

PMID: 28285100 PMC: 5985517. DOI: 10.1016/j.tox.2017.03.007.


References
1.
Schultz G, Wysocki A . Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 2009; 17(2):153-62. DOI: 10.1111/j.1524-475X.2009.00466.x. View

2.
Branski L, Herndon D, Pereira C, Mlcak R, Celis M, Lee J . Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med. 2007; 35(11):2615-23. DOI: 10.1097/01.CCM.0000285991.36698.E2. View

3.
Middelkoop E, van den Bogaerdt A, Lamme E, Hoekstra M, BRANDSMA K, Ulrich M . Porcine wound models for skin substitution and burn treatment. Biomaterials. 2003; 25(9):1559-67. DOI: 10.1016/s0142-9612(03)00502-7. View

4.
Helary C, Zarka M, Giraud-Guille M . Fibroblasts within concentrated collagen hydrogels favour chronic skin wound healing. J Tissue Eng Regen Med. 2012; 6(3):225-37. DOI: 10.1002/term.420. View

5.
Bottcher-Haberzeth S, Biedermann T, Pontiggia L, Braziulis E, Schiestl C, Hendriks B . Human eccrine sweat gland cells turn into melanin-uptaking keratinocytes in dermo-epidermal skin substitutes. J Invest Dermatol. 2012; 133(2):316-24. DOI: 10.1038/jid.2012.290. View